Literature DB >> 227794

Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.

J Robinson, A Frank, E Henderson, J Schweitzer, G Miller.   

Abstract

We characterized subpopulations of lymphocytes in human umbilical cord blood which are stimulated into deoxyribonucleic acid synthesis by Epstein-Barr virus. Lymphocytes were examined simultaneously for deoxyribonucleic acid synthesis by autoradiography and for surface markers by rosette formation with sheep erythrocytes or erythrocytes coated with antibody and mouse complement (EAC). The subpopulation which incorporated [3H]thymidine after exposure to virus consisted mainly of cells which formed rosettes with EAC. Lymphocytes were enriched or depleted of thymus-derived lymphocytes (T cells), null cells, or cells forming rosettes with EAC. The extent of sensitivity of the cells to stimulation by Epstein-Barr virus correlated with the proportion of the population which formed rosettes with EAC. When mononuclear cell populations were depleted of T lymphocytes and then fractionated by size, small lymphocytes showed higher rates of deoxyribonucleic acid synthesis after virus exposure and higher transformation frequency than did larger cells or unfractionated cells. Thus, the cells which are stimulated into deoxyribonucleic acid synthesis by Epstein-Barr virus appear to be the same as cells which are ultimately transformed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227794      PMCID: PMC414599          DOI: 10.1128/iai.26.1.225-231.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Epstein-Barr virus: transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light.

Authors:  E Henderson; J Robinson; A Frank; G Miller
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

2.  Efficiency of transformation of lymphocytes by Epstein-Barr virus.

Authors:  E Henderson; G Miller; J Robinson; L Heston
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

3.  Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies.

Authors:  L Einhorn; M Steinitz; E Yefenof; I Ernberg; T Bakacs; G Klein
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

4.  Separation of lymphoid-line cells according to volume and density.

Authors:  T A Splinter; M Reiss
Journal:  Exp Cell Res       Date:  1974-12       Impact factor: 3.905

5.  B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus.

Authors:  P K Pattengale; R W Smith; P Gerber
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

6.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

7.  Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation.

Authors:  U Schneider; H zur Hausen
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

8.  Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.

Authors:  J E Robinson; W A Andiman; E Henderson; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.

Authors:  G Miller; M Lipman
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  5 in total

1.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

2.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Frequency of B-lymphocyte transformation by Epstein-Barr virus decreases with entry into the cell cycle.

Authors:  A J Roome; C L Reading
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

4.  When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

Authors:  E A Hurley; S Agger; J A McNeil; J B Lawrence; A Calendar; G Lenoir; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Epstein-Barr virus susceptibility of normal human B lymphocyte populations.

Authors:  P Aman; B Ehlin-Henriksson; G Klein
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.